Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Pemphigus Vulgaris in a Patient With Multiple Sclerosis: A Case Report With 7 Years of Follow Up Publisher



Shirani AM1 ; Khosravi M1 ; Ardestani M2 ; Ashtari F3
Authors

Source: Journal of Research in Dental and Maxillofacial Sciences Published:2023


Abstract

Background and Aim: Pemphigus vulgaris (PV) is a severe life-threatening autoimmune disease that causes intraepithelial blisters. PV has been reported in association with some autoimmune diseases. But only few cases (fewer than 10 reports according to literature search) have been reported regarding the association of PV with multiple sclerosis (MS). MS is a life-threatening, inflammatory demyelinating disease, causing severe disability. Case Presentation: Our patient was a 40-year-old female complaining of gingival ulcers. She had MS for the past 10 years. Biopsy and immunoassay were done and PV was confirmed. The patient has been followed up for 7 years so far. Conclusion: It is necessary to pay attention to mild oral ulcers in MS patients because they may be related to severe blistering diseases like PV. © 2023 Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University.
Related Docs
View other Related Docs
1. Demographic, Clinical, and Paraclinical Characteristics of Patients With Pemphigus Vulgaris Needing Hospital Admission During the Years 2006-2017, Journal of Isfahan Medical School (2018)
2. The Use of Oral Cyclophosphamide With Dexamethasone Pulse Therapy in the Treatment of Pemphigus Vulgaris, Journal of Dermatological Treatment (2007)
3. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (8)
Vahid Shaygannejad (4)
Other Related Docs
4. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
5. Cancer Risk Among Patients With Multiple Sclerosis: A Cohort Study in Isfahan, Iran, Caspian Journal of Internal Medicine (2017)
6. Cow's Milk Allergy in Multiple Sclerosis Patients, Journal of Research in Medical Sciences (2013)
7. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine, Journal of Complementary and Integrative Medicine (2022)
8. Study of Apoptosis in Oral Pemphigus Vulgaris Using Immunohistochemical Marker Bax and Tunel Technique, Journal of Oral Pathology and Medicine (2013)
9. The Levels of Soluble Forms of Cd21 and Cd83 in Multiple Sclerosis, Journal of Neuroimmunology (2018)
10. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)
11. Insights Into the Interplay Between Epstein-Barr Virus (Ebv) and Multiple Sclerosis (Ms): A State-Of-The-Art Review and Implications for Vaccine Development, Health Science Reports (2024)
12. Tnf-Alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls, Immunological Investigations (2015)
13. Successful Treatment of Pemphigus Vulgaris With the Extensive Mucocutaneous Lesions in an Elderly Patient, Iranian Red Crescent Medical Journal (2014)
14. Linkage of Multiple Sclerosis and Guillain-Barre Syndrome: A Population-Based Survey in Isfahan, Iran, Autoimmune Diseases (2012)
15. Decreased Expression of Sema3a, an Immune Modulator, in Blood Sample of Multiple Sclerosis Patients, Gene (2017)
16. Association Between Dietary Inflammatory Index and Risk of Demyelinating Autoimmune Diseases: A Cross-Sectional Study, International Journal for Vitamin and Nutrition Research (2024)
17. Evaluation of Interleukin-1Α, Interleukin-10, Tumor Necrosis Factor-Α and Transforming Growth Factor-Β in the Serum of Patients With Pemphigus Vulgaris, Journal of Contemporary Dental Practice (2015)
18. Facial Involvement in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
19. Serum Level of Interleukin 36 in Patients With Multiple Sclerosis, Journal of Immunoassay and Immunochemistry (2018)
20. Toll Like Receptor 2 and 4 Expression in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, Iranian Journal of Immunology (2014)